Kennedy Jr., President Trump’s nominee to run the Department of Health and Human Services, is giving away the fees that he could earn from litigation over Merck’s HPV vaccine Gardasil — to ...

Mr. Kennedy said that he had sent hundreds of clients to the firm, which is suing the drug maker Merck over claims that young people were injured by the company’s Gardasil vaccine, aimed at ...

Kennedy Jr. told lawmakers in response to questions released on Friday that he would divest his interest in litigation against a major HPV vaccine maker and would sign over the financial stake to ...

President Donald Trump’s pick for secretary of Health and Human Services said he will divest his interest in lawsuits against an HPV vaccine manufacturer. In written responses to questions from Sen.

GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1 ...

The approval makes GARDASIL the first HPV vaccine approved for use in males in China. GARDASIL is now indicated in China to prevent anal cancers caused by HPV Types 16 and 18, genital warts ...

Public health researchers and doctors said there was no evidence that the vaccine, Gardasil, was linked to the health problems he cited, noting 160 favorable studies on safety. A federal court ...

Cervical cancer has been widely impacting women's health and the World Health Organisation terms it as a significant public health challenge that must be addressed on a global scale. In India ...

The first human papillomavirus (HPV) vaccine, Gardasil, became FDA-approved back in 2006. Since then, HPV vaccines have become a part of the national immunization schedule of at least 145 ...

That included an arrangement with a law firm that's sued Merck over Gardasil, its human papillomavirus vaccine that prevents cervical cancer. The deal earned Kennedy $850,000 last year ...

RFK Jr. Says He'll Stop Collecting Fees From HPV Vaccine Lawsuit, but Other Ethics Questions Remain WASHINGTON (AP) — Facing intense scrutiny from senators over his potential profit from vaccine ...